There are other studies that show the benefit of mineralocorticoid antagonists in the mrHF and pefHF, with impact on reduced myocardial fibrosis, arrhythmias, brain natriuretic peptides, and the 6 min walking test [24,25]. This evidence concerns the gene NPPB and Arrhythmia.